By |

Profile

IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.

Contact Information

Website: www.imvaccine.com
Email: info@imvaccine.com
Main Phone: +1 902 492-1819
Address: 130 Eileen Stubbs
Address 2: Suite 19
State: NS
City / Town: Dartmouth
Country: CAN
Postal Code: B3B 2C4

Issuer Information

Exchange: CDX
CEO: Frederic Ors
Employees: 51
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.

Contact Information

Website: www.imvaccine.com
Email: info@imvaccine.com
Main Phone: +1 902 492-1819
Address: 130 Eileen Stubbs
Address 2: Suite 19
State: NS
City / Town: Dartmouth
Country: CAN
Postal Code: B3B 2C4

Issuer Information

Exchange: CDX
CEO: Frederic Ors
Employees: 51
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2.5 2.5 2.5 2.5
Low Target Price Estimate 2.2 2.2 2.2 2.2
Mean Target Price Estimate 2.35 2.35 2.35 2.35
Standard Deviation 0.21 0.21 0.21 0.21
Date of Most Recent Estimate 09/20/17 09/20/17 09/20/17 09/20/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.65 1.65 1.65 2.3